
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gout
Nicola Dalbeth, Anna L. Gosling, Angelo Gaffo, et al.
The Lancet (2021) Vol. 397, Iss. 10287, pp. 1843-1855
Closed Access | Times Cited: 778
Nicola Dalbeth, Anna L. Gosling, Angelo Gaffo, et al.
The Lancet (2021) Vol. 397, Iss. 10287, pp. 1843-1855
Closed Access | Times Cited: 778
Showing 26-50 of 778 citing articles:
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development
Eder Orlando Méndez-Salazar, Gabriela Angélica Martínez‐Nava
Rheumatology International (2021) Vol. 42, Iss. 3, pp. 403-412
Closed Access | Times Cited: 60
Eder Orlando Méndez-Salazar, Gabriela Angélica Martínez‐Nava
Rheumatology International (2021) Vol. 42, Iss. 3, pp. 403-412
Closed Access | Times Cited: 60
Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 60
Hitoshi Nishizawa, Norikazu Maeda, Iichiro Shimomura
Hypertension Research (2022) Vol. 45, Iss. 4, pp. 635-640
Closed Access | Times Cited: 60
Trend dynamics of gout prevalence among the Chinese population, 1990-2019: A joinpoint and age-period-cohort analysis
Bowen Zhu, Yimei Wang, Weiran Zhou, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 59
Bowen Zhu, Yimei Wang, Weiran Zhou, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 59
Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases
Tomohiko Murakami, Yuri Nakaminami, Yoshifumi Takahata, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5365-5365
Open Access | Times Cited: 46
Tomohiko Murakami, Yuri Nakaminami, Yoshifumi Takahata, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5365-5365
Open Access | Times Cited: 46
Environmental factors and risk of gout
Zhengdong Wu, Xiao‐Ke Yang, Yisheng He, et al.
Environmental Research (2022) Vol. 212, pp. 113377-113377
Closed Access | Times Cited: 44
Zhengdong Wu, Xiao‐Ke Yang, Yisheng He, et al.
Environmental Research (2022) Vol. 212, pp. 113377-113377
Closed Access | Times Cited: 44
Recent advances in gout drugs
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 41
Cheng Shi, Ziting Zhou, Xiaowei Chi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114890-114890
Closed Access | Times Cited: 41
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 32
Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management
Yao Yang, Zimu Li, Ping Huang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3454-3470
Open Access | Times Cited: 31
Yao Yang, Zimu Li, Ping Huang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3454-3470
Open Access | Times Cited: 31
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout
Jawad H. Butt, Kieran F. Docherty, Brian Claggett, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 4, pp. 386-386
Open Access | Times Cited: 29
Jawad H. Butt, Kieran F. Docherty, Brian Claggett, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 4, pp. 386-386
Open Access | Times Cited: 29
Role of pyroptosis in the pathogenesis and treatment of diseases
Xiangyu Jin, Yinchu Ma, Didi Liu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 28
Xiangyu Jin, Yinchu Ma, Didi Liu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 28
Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
Wei Yu, De Xie, Tetsuya Yamamoto, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 2, pp. 327-343
Closed Access | Times Cited: 26
Wei Yu, De Xie, Tetsuya Yamamoto, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 2, pp. 327-343
Closed Access | Times Cited: 26
A review on gout: Looking back and looking ahead
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 26
Haolin Tao, Yingshi Mo, Wenbin Liu, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109977-109977
Closed Access | Times Cited: 26
Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes
Jie Wei, Hyon K. Choi, Nicola Dalbeth, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2330885-e2330885
Open Access | Times Cited: 25
Jie Wei, Hyon K. Choi, Nicola Dalbeth, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2330885-e2330885
Open Access | Times Cited: 25
Gout therapeutics and drug delivery
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 24
Xiuju Peng, Xiaotong Li, Bing Xie, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 728-754
Closed Access | Times Cited: 24
New Inflammatory Marker Associated with Disease Activity in Gouty Arthritis: The Systemic Inflammatory Response Index
Yi Jiang, Xin Tu, Xia Liao, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5565-5573
Open Access | Times Cited: 24
Yi Jiang, Xin Tu, Xia Liao, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 5565-5573
Open Access | Times Cited: 24
The gout epidemic in French Polynesia: a modelling study of data from the Ma’i u’u epidemiological survey
Tristan Pascart, Kaja A. Wasik, Cristian Preda, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 4, pp. e685-e696
Open Access | Times Cited: 13
Tristan Pascart, Kaja A. Wasik, Cristian Preda, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 4, pp. e685-e696
Open Access | Times Cited: 13
Structural basis for urate recognition and apigenin inhibition of human GLUT9
Zilin Shen, Xu Li, Tong Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Zilin Shen, Xu Li, Tong Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Lactobacillus rhamnosus GG ameliorates hyperuricemia in a novel model
Yang Fu, Yong‐Song Chen, Daiyang Xia, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Yang Fu, Yong‐Song Chen, Daiyang Xia, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Bisphenol A and its alternatives bisphenol S and F exposure with serum uric acid levels, hyperuricemia, and gout prevalence among US adults: a nationally representative cross-sectional study
Shunli Jiang, Yongxin Wang, Zengliang Wang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Shunli Jiang, Yongxin Wang, Zengliang Wang, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis
Xin Huang, Weiyue Zhang
Ageing Research Reviews (2024) Vol. 95, pp. 102241-102241
Open Access | Times Cited: 9
Xin Huang, Weiyue Zhang
Ageing Research Reviews (2024) Vol. 95, pp. 102241-102241
Open Access | Times Cited: 9
Unveiling potent Schiff base derivatives with selective xanthine oxidase inhibition: In silico and in vitro approach
Fatna Bellahcene, Khedidja Benarous, Arif Mermer, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102062-102062
Open Access | Times Cited: 9
Fatna Bellahcene, Khedidja Benarous, Arif Mermer, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102062-102062
Open Access | Times Cited: 9
Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome
Xinghong Zhou, Shuai Ji, Liqian Chen, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Xinghong Zhou, Shuai Ji, Liqian Chen, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Effects and mechanisms of Polygonati Rhizoma polysaccharide on potassium oxonate and hypoxanthine-induced hyperuricemia in mice
Nanxin Zhang, Bichen Zhang, Xiangjun Chen, et al.
International Journal of Biological Macromolecules (2024), pp. 135550-135550
Closed Access | Times Cited: 9
Nanxin Zhang, Bichen Zhang, Xiangjun Chen, et al.
International Journal of Biological Macromolecules (2024), pp. 135550-135550
Closed Access | Times Cited: 9
Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the United States
Ruoyu Gou, Danni Dou, Mi Tian, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 8
Ruoyu Gou, Danni Dou, Mi Tian, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 8
Plug-In Design of the Microneedle Electrode Array for Multi-Parameter Biochemical Sensing in Gouty Arthritis
Zhibo Liu, Xinshuo Huang, Zhengjie Liu, et al.
ACS Sensors (2025)
Closed Access | Times Cited: 1
Zhibo Liu, Xinshuo Huang, Zhengjie Liu, et al.
ACS Sensors (2025)
Closed Access | Times Cited: 1